If I had a gene test, what would I have and who would I tell?

[1]  P. Devilee.  BRCA1 and BRCA2 testing: weighing the demand against the benefits. , 1999, American journal of human genetics.

[2]  S Wacholder,et al.  The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. , 1999, American journal of human genetics.

[3]  D. Steinberg,et al.  Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[4]  S. Gallinger,et al.  Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism. , 1999, American journal of human genetics.

[5]  J. Poirier,et al.  Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer's disease. , 1998, Journal of neural transmission. Supplementum.

[6]  S. Powell.  Direct analysis for familial adenomatous polyposis mutations , 2002, Molecular biotechnology.

[7]  J. Rüschoff,et al.  Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Robbins,et al.  Systematic analysis of hMSH2 and hMLH1 in young colon cancer patients and controls. , 1998, American journal of human genetics.

[9]  P. Reilly,et al.  Rethinking risks to human subjects in genetic research. , 1998, American journal of human genetics.

[10]  A. Zwinderman,et al.  Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. , 1998, The New England journal of medicine.

[11]  F. Collins,et al.  Hereditary hemochromatosis: gene discovery and its implications for population-based screening. , 1998, JAMA.

[12]  T. Bird,et al.  Recent Advances in the Genetics of Alzheimer's Disease , 1998, Journal of geriatric psychiatry and neurology.

[13]  Z. Cohen,et al.  Genotype-phenotype correlations in attenuated adenomatous polyposis coli. , 1998, American journal of human genetics.

[14]  T. Smyrk,et al.  Classification of familial adenomatous polyposis: a diagnostic nightmare. , 1998, American journal of human genetics.

[15]  E. Beutler,et al.  HLA-H mutations in the Ashkenazi Jewish population. , 1997, Blood cells, molecules & diseases.

[16]  G. Petersen,et al.  The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. , 1997, The New England journal of medicine.

[17]  J. Brockmöller,et al.  Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. , 1997, American journal of human genetics.

[18]  F. Luft,et al.  Oligonucleotide ligation assay (OLA) for the diagnosis of familial hypercholesterolemia , 1996, Nature Biotechnology.

[19]  S. Lovestone,et al.  Consensus Statement on Predictive Testing for Alzheimer Disease , 1995, Alzheimer disease and associated disorders.

[20]  Lori B. Andrews,et al.  Assessing Genetic Risks: Implications for Health and Social Policy , 1994 .

[21]  D. Easton,et al.  Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.

[22]  V. Herrera,et al.  Genetic analysis of hypertension in animal models and human hypertensive patients , 1994, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.